EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Cancer Cachexia Index Can Be Used to Prognostically Predict Patients with Gastric Cancer Undergoing Gastrectomy

Katsunobu Sakurai, Naoshi Kubo, Tsuyoshi Hasegawa, Junya Nishimura, Yasuhito Iseki, Takafumi Nishii, Toru Inoue, Masakazu Yashiro, Yukio Nishiguchi, Kiyoshi Maeda

Annals of Nutrition and Metabolism · 2023

DOI: 10.1159/000534244 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Nutrition and Metabolism, 2023. Verfasst von Katsunobu Sakurai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Osaka City General Hospital, Osaka, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cancer cachexia occurs in cancer patients more frequently as the cancer progresses, with a negative impact on treatment outcomes. In this study, we sought to clarify the clinical impact of a cancer cachexia index (CXI) in patients with gastric cancer (GC) undergoing gastrectomy.

Methods

Between January 2013 and December 2018, we reviewed data from 556 patients treated for GC at our hospital. CXI was calculated using skeletal muscle index (SMI), serum albumin, and neutrophil-lymphocyte ratios (NLR). Patients were divided into high (n = 414) or low CXI (n = 142) groups. We investigated the clinical impact of CXI in patients with GC undergoing gastrectomy.

Results

Multivariate analyses of 5-year overall survival (OS) and cancer-specific survival (CSS) rates indicated that a low CXI was independently associated with unfavorable outcomes for patients with GC. In multivariate analyses, SMI was independent predictor of OS but not CSS. NLR was not an independent predictor of either OS or CSS. Complication incidences (≥ Clavien Dindo 3) were non-significantly higher in the low (vs. high) CXI group.

Conclusion

CXI was a more valuable prognostic biomarker when compared with SMI or NLR in GC patients undergoing gastrectomy. We suggest that patients with low CXI values should be given more comprehensive treatment, including exercise and nutritional therapy to improve clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsHumansPrognosisCachexiaTreatment OutcomeGastrectomyRetrospective Studies

Stichwörter der Autor:innen

CachexiaGastrectomyGastric cancerPrognostic factor

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Osaka City General Hospital, Osaka, Japan.
  • Department of Gastroenterological Surgery, Osaka Metropolitan University, Osaka, Japan.

Zitieren

APA

Sakurai, K., Kubo, N., Hasegawa, T., Nishimura, J., Iseki, Y., Nishii, T., Inoue, T., Yashiro, M., Nishiguchi, Y., & Maeda, K. (2023). The Cancer Cachexia Index Can Be Used to Prognostically Predict Patients with Gastric Cancer Undergoing Gastrectomy. Annals of Nutrition and Metabolism. https://doi.org/10.1159/000534244

Vancouver

Sakurai K, Kubo N, Hasegawa T, Nishimura J, Iseki Y, Nishii T, et al. The Cancer Cachexia Index Can Be Used to Prognostically Predict Patients with Gastric Cancer Undergoing Gastrectomy. Annals of Nutrition and Metabolism. 2023. doi:10.1159/000534244

BibTeX
@article{Sakurai2023,
  author = {Sakurai, Katsunobu and Kubo, Naoshi and Hasegawa, Tsuyoshi and Nishimura, Junya and Iseki, Yasuhito and Nishii, Takafumi and Inoue, Toru and Yashiro, Masakazu and Nishiguchi, Yukio and Maeda, Kiyoshi},
  title = {The Cancer Cachexia Index Can Be Used to Prognostically Predict Patients with Gastric Cancer Undergoing Gastrectomy},
  journal = {Annals of Nutrition and Metabolism},
  year = {2023},
  doi = {10.1159/000534244}
}
Kostenlos starten →